Saturday, October 6, 2018: 10:30 AM-11:45 AM
Room: N 25
At the conclusion of this session, participants will be able to:
- discuss novel and cutting edge approaches to discover antibiotics
- evaluate chemical strategies to modify antibiotics and provide new strictures with potential clinical utility.
- discuss the discovery of antibiotics using a deep understanding of host-pathogen interactions.
Academicians, Clinicians, Investigators, Lab personnel, Microbiologists, Pharmacists, Researchers, Scientists
Investigative ID, Pediatric ID, Trainee, Adult ID
Cesar Arias, MD, PhD, FIDSA, University of Texas Health Science Center at Houston
David R. Andes, M.D., FIDSA, University of Wisconsin School of Medicine and Public Health
Robert Bonomo, MD, Louis Stokes Cleveland VA Medical Center
Maximum of 1.25 hours of AMA PRA Category 1 Credit™
ACPE 1.25 knowledge-based contact hours of pharmacy CE
Merck & Co., Inc.:
D. R. Andes,